eAbbvie
Pharmaceutical Product Catalog

Effective January 1, 2019, VIEKIRA XR and TECHNIVIE will no longer be available in the U.S.A. Until January 1, 2019, supply of these medications will be available for all patients who begin therapy prior to July 1, 2018, to ensure that they are able to obtain product necessary to complete their course of prescribed therapy. Accordingly, AbbVie advises that physicians should cease writing any new prescriptions for VIEKIRA XR and TECHNIVIE effective July 1, 2018.

By NDC Number
By Product Description
By Alphabet
Select Alphabet
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z dummyspnl 
By Therapeutic Class
New Item
Material Safety Data Sheet
Security Flyer
Announcement
Search Results By: Product Family
DEPAKENE > All Therapeutic Classes
ImageNDC NumberProduct DescriptionList PriceWAC PriceOthers
00074568113 DEPAKENE 250MG 100CAP $523.97 $497.77

Product and pricing detail may change. Please return to www.e-abbvie.com for the current product and pricing information.
Copyright © Abbvie Version 2.5